News and Trends 29 Jul 2024Influenza solution deals pile up as pandemic preparedness increases Influenza deals have been piling up in the last few weeks. Discover why that is and how are companies and government preparing for pandemics. July 29, 2024 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 26 Jul 2024Confo Therapeutics raises $60 million to focus on agonistic GPCR antibodies Discover the field of agonistic GPCR antibodies after Confo therapeutics successfully raised $60 million in its series B round. July 26, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 23 Jul 2024First AKT-targeting drug capivasertib to hit the market, could it open the door for more? As AstraZeneca and Astex’s capivasertib gains market presence in breast cancer, could it be the time for AKT inhibitors? Let’s find out! July 23, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 17 Jul 2024Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it Discover yet another exciting deal in biotech with Asceneuron raising $100 million to advance its Alzheimer’s candidate, ASN51. July 17, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jul 2024German biotech raises $150M on its way to tackle cancer therapy resistance On its way to tackle cancer therapy resistance with its monoclonal antibody visugromab, CataLym completes a $150 million series D round. July 16, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 11 Jul 2024CDMO trends post-Wuxi’s exit from the US: who will take its place? The BIOSECURE Act is reshuffling the deck and Indian CDMOs are looking good. Discover the trends in this evolving landscape. July 11, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 27 May 2024New report shows that Swiss biotech capital investment surged last year With a record revenue of $8 billion in 2023, Swiss biotech appears robust in 2024. Delve into the findings of the Swiss Biotech Report 2024. May 27, 2024 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 18 Apr 2024Biotech under surveillance: The global impact of the WuXi AppTec controversy Delve into the ongoing controversy involving the Chinese company WuXi AppTec and the possible impact on U.S. national security measures. April 18, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 1 Feb 2024Can gene therapy be the key to restoring hearing loss? Explore gene therapy’s success in treating genetic hearing loss as a child regains hearing at the Children’s Hospital of Philadelphia. February 1, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 20242024 J.P. Morgan Healthcare Conference: key takeaways from the largest biotech gathering of the year Here are some of the key takeaways from the JPM Healthcare Conference that lay the groundwork for what we can expect in 2024. January 18, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jan 2024AI and a brain organoid: can this combo take on supercomputers? Explore the groundbreaking fusion of brain organoids and AI in the creation of Brainoware, the world’s first biohybrid computer. January 12, 2024 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jan 2024Is the biotech industry poised for recovery in 2024? The past few years have been challenging for the industry but 2024 might be the year marking the biotech recovery. January 8, 2024 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email